Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial

IMPORTANCE: The role of primary tumor resection (PTR) in synchronous patients with metastatic colorectal cancer (mCRC) who had unresectable metastases and few or absent symptoms of their primary tumor is unclear. Studying subgroups with low postoperative mortality may identify patients who potential...

Full description

Saved in:

Bibliographic Details
Main Authors:	van der Kruijssen, Dave E. W., Elias, Sjoerd G., Vink, Geraldine R., van Rooijen, Karlijn L., ‘t Lam-Boer, Jorine, Mol, Linda, Punt, Cornelis J. A., de Wilt, Johannes H. W., Koopman, Miriam
Format:	Text
Language:	English
Published:	American Medical Association 2021
Subjects:	Original Investigation
Online Access:	https://pmc.ncbi.nlm.nih.gov/articles/PMC8495602/ https://pubmed.ncbi.nlm.nih.gov/34613339 http://dx.doi.org/10.1001/jamasurg.2021.4992
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://pmc.ncbi.nlm.nih.gov/articles/PMC8495602/
https://pubmed.ncbi.nlm.nih.gov/34613339
http://dx.doi.org/10.1001/jamasurg.2021.4992

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial

Internet

Similar Items